Gemtuzumab Ozogamicin
Records for this ingredient, by country (identity only).
ATC L01FX02 · 11 markets · 14 records
AU 3 records · 1 shown of 1
- 5 mg per mL / per unit basis not statedinjectionMylotargMYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 2 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 shown of 1
- 5 mg/5 mLinjectionMylotarg
GB 1 records · 1 shown of 1
- 5 mg per mL / per unit basis not statedinjectionMylotarg 5mg powder for concentrate for solution for infusion vials
CA 1 records · 1 shown of 1
- 4.5 mgpowderMylotarg
SG 1 records · 1 shown of 1
- 5 mg/vialpowderMYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL
ES 1 records · 1 shown of 1
- 5 mg per mL / per unit basis not statedinjectionMylotarg
TW 1 records · 1 shown of 1
- 5 mg per mL / per unit basis not statedinjectionMYLOTARG 5 mg powder for concentrate for solution for infusion滅髓瘤凍晶注射劑5毫克
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 1 records · 1 shown of 1
- 5 mg per mL / per unit basis not statedinjectionマイロターグ点滴静注用5mg
FR 1 records · 1 shown of 1
- 5 mg per mL / per unit basis not statedinjectionMYLOTARG 5 mg, poudre pour solution à diluer pour perfusion
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | JP | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 mg per mL / per unit basis not stated cannot compare injection | Mylotarg 5mg powder for concentrate for solution for infusion vials | Mylotarg MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial | Mylotarg | MYLOTARG 5 mg powder for concentrate for solution for infusion 滅髓瘤凍晶注射劑5毫克 | マイロターグ点滴静注用5mg | MYLOTARG 5 mg, poudre pour solution à diluer pour perfusion | |||||
| 5 mg/5 mL injection | Mylotarg | ||||||||||
| 5 mg/vial powder | MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL | ||||||||||
| 4.5 mg powder | Mylotarg | ||||||||||
unknown | Mylotarg | MYLOTARG 5 mg powder for concentrate for solution for infusion | Mylotarg Mylotarg Refusal |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in CA · SG and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · SG que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · SG 有记录（未在本表显示）。 另有 2 個規格/劑型僅在 CA · SG 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.